109 related articles for article (PubMed ID: 2822456)
1. Effect of immunization and immunosuppression on induced ocular shedding and recovery of herpes simplex virus in infected rabbits.
Green MT; Dunkel EC; Pavan-Langston D
Exp Eye Res; 1987 Sep; 45(3):375-83. PubMed ID: 2822456
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of local PD-1+ TIM-3+ CD8+ exhausted T cells.
Khan AA; Srivastava R; Chentoufi AA; Geertsema R; Thai NT; Dasgupta G; Osorio N; Kalantari M; Nesburn AB; Wechsler SL; BenMohamed L
J Virol; 2015 Jul; 89(13):6619-32. PubMed ID: 25878105
[TBL] [Abstract][Full Text] [Related]
3. Herpes simplex virus recovery in neural tissues after ocular HSV shedding induced by epinephrine iontophoresis to the rabbit cornea.
Hill JM; Kwon BS; Shimomura Y; Colborn GL; Yaghmai F; Gangarosa LP
Invest Ophthalmol Vis Sci; 1983 Feb; 24(2):243-7. PubMed ID: 6298139
[TBL] [Abstract][Full Text] [Related]
4. Strain specificity of spontaneous and adrenergically induced HSV-1 ocular reactivation in latently infected rabbits.
Hill JM; Rayfield MA; Haruta Y
Curr Eye Res; 1987 Jan; 6(1):91-7. PubMed ID: 3030660
[TBL] [Abstract][Full Text] [Related]
5. Passive immunization protects the mouse eye from damage after herpes simplex virus infection by limiting spread of virus in the nervous system.
Shimeld C; Hill TJ; Blyth WA; Easty DL
J Gen Virol; 1990 Mar; 71 ( Pt 3)():681-7. PubMed ID: 2156001
[TBL] [Abstract][Full Text] [Related]
6. In vivo reactivation of herpes simplex virus in rabbit trigeminal ganglia: electrode model.
Green MT; Rosborough JP; Dunkel EC
Infect Immun; 1981 Oct; 34(1):69-74. PubMed ID: 6271686
[TBL] [Abstract][Full Text] [Related]
7. Ocular infection with herpes simplex virus type 1: prevention of acute herpetic encephalitis by systemic administration of virus-specific antibody.
Davis WB; Taylor JA; Oakes JE
J Infect Dis; 1979 Oct; 140(4):534-40. PubMed ID: 229174
[TBL] [Abstract][Full Text] [Related]
8. Protective immunity against herpetic ocular disease in an outbred mouse model.
Metcalf JF; Whitley RJ
Curr Eye Res; 1987 Jan; 6(1):167-71. PubMed ID: 3030641
[TBL] [Abstract][Full Text] [Related]
9. Induction of ocular herpes simplex virus shedding by iontophoresis of epinephrine into rabbit cornea.
Kwon BS; Gangarosa LP; Burch KD; deBack J; Hill JM
Invest Ophthalmol Vis Sci; 1981 Sep; 21(3):442-9. PubMed ID: 6268564
[TBL] [Abstract][Full Text] [Related]
10. The effect of trigeminal nerve and ganglion manipulation on recurrence of ocular herpes simplex in rabbits.
Nesburn AB; Dickinson R; Radnoti M
Invest Ophthalmol; 1976 Sep; 15(9):726-31. PubMed ID: 183501
[TBL] [Abstract][Full Text] [Related]
11. Spread of virus and distribution of latent infection following ocular herpes simplex in the non-immune and immune mouse.
Tullo AB; Shimeld C; Blyth WA; Hill TJ; Easty DL
J Gen Virol; 1982 Nov; 63 (Pt 1)():95-101. PubMed ID: 6294236
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppression promotes ocular virus replication and CNS neurovirulence following corneal inoculation with an avirulent herpes simplex type 1 thymidine kinase negative mutant.
Gordon YJ; Rao H; Arullo-Cruz T
Curr Eye Res; 1984 Apr; 3(4):651-7. PubMed ID: 6325093
[TBL] [Abstract][Full Text] [Related]
13. Ocular herpes simplex virus reactivation in mice latently infected with latency-associated transcript mutants.
Cook SD; Paveloff MJ; Doucet JJ; Cottingham AJ; Sedarati F; Hill JM
Invest Ophthalmol Vis Sci; 1991 Apr; 32(5):1558-61. PubMed ID: 1849874
[TBL] [Abstract][Full Text] [Related]
14. Effect of intensive acyclovir therapy during artificial reactivation of latent herpes simplex virus.
Nesburn AB; Willey DE; Trousdale MD
Proc Soc Exp Biol Med; 1983 Mar; 172(3):316-23. PubMed ID: 6302707
[TBL] [Abstract][Full Text] [Related]
15. Quantitation and kinetics of induced HSV-1 ocular shedding.
Hill JM; Dudley JB; Shimomura Y; Kaufman HE
Curr Eye Res; 1986 Mar; 5(3):241-6. PubMed ID: 3009094
[TBL] [Abstract][Full Text] [Related]
16. CXCL10/CXCR3-Dependent Mobilization of Herpes Simplex Virus-Specific CD8
Srivastava R; Khan AA; Chilukuri S; Syed SA; Tran TT; Furness J; Bahraoui E; BenMohamed L
J Virol; 2017 Jul; 91(14):. PubMed ID: 28468883
[TBL] [Abstract][Full Text] [Related]
17. Experimental reactivation of ocular herpes simplex in rabbits.
Nesburn AB; Dickinson R; Radnoti M; Green MJ
Surv Ophthalmol; 1976; 21(2):185-90. PubMed ID: 185740
[TBL] [Abstract][Full Text] [Related]
18. A therapeutic vaccine that reduces recurrent herpes simplex virus type 1 corneal disease.
Nesburn AB; Burke RL; Ghiasi H; Slanina SM; Wechsler SL
Invest Ophthalmol Vis Sci; 1998 Jun; 39(7):1163-70. PubMed ID: 9620075
[TBL] [Abstract][Full Text] [Related]
19. Recovery of herpes simplex virus from the corneas of experimentally infected rabbits.
Cook SD; Batra SK; Brown SM
J Gen Virol; 1987 Jul; 68 ( Pt 7)():2013-7. PubMed ID: 3037020
[TBL] [Abstract][Full Text] [Related]
20. Reliable in vivo model for latent herpes simplex virus reactivation with peripheral virus shedding.
Nesburn AB; Green MT; Radnoti M; Walker B
Infect Immun; 1977 Mar; 15(3):772-5. PubMed ID: 192675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
